MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair

Cell Cycle

Volumn 11, Issue 5, 2012, Pages 877-886

  Perdiguero, Eusebio ^a   Kharraz, Yacine ^a   Serrano, Antonio L ^a   Muñoz Cánoves, Pura ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Inflammation; MKP 1; p38 MAP kinase; Regeneration; Satellite cells

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CELL ACTIVATION; CELL DAMAGE; CELL POLARITY; CYTOKINE RELEASE; ENZYME DEFICIENCY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HELMINTHIASIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; MEDIATOR RELEASE; MUSCLE FUNCTION; MUSCLE TISSUE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROTEIN DEPLETION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL; TH2 CELL; TISSUE INJURY; TISSUE REPAIR;

BACTERIA (MICROORGANISMS); MUS;

EID: 84857955811     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.5.19374     Document Type: Review

References (65)

1. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11:723-37; PMID:21997792; http://dx.doi.org/10. 1038/nri3073.
2. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011; 11:750-61; PMID:22025054; http://dx.doi.org/10.1038/nri3088.
3. Serrano AL, Muñoz-Cánoves P. Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 2010; 316:3050-8; PMID:20570674; http://dx.doi.org/10.1016/j.yexcr.2010.05.035.
4. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 2011; 1:21; PMID:21798099; http://dx.doi.org/10.1186/2044-5040-1-21.
5. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006; 10:233; PMID:17044947; http://dx.doi.org/10.1186/cc5055.
6. Morris M, Li L. Molecular Mechanisms and Pathological Consequences of Endotoxin Tolerance and Priming. Arch Immunol Ther Exp (Warsz) 2011.
7. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30:475-87; PMID:19781994; http://dx.doi.org/10.1016/j.it.2009.07.009.
8. Chawla A, Nguyen KD, Goh YP. Macrophagemediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11:738-49; PMID:21984069; http://dx.doi.org/10. 1038/nri3071.
9. Chow A, Brown BD, Merad M. Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol 2011; 11:788-98; PMID:22025056; http://dx.doi.org/10.1038/nri3087.
10. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74; PMID:21984070; http://dx.doi.org/10.1038/ nri3070.
11. Sahay B, Patsey RL, Eggers CH, Salazar JC, Radolf JD, Sellati TJ. CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog 2009; 5:1000687; PMID:20011115; http://dx.doi.org/10.1371/journal.ppat.1000687.
12. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010; 298:1173-87; PMID:20219869; http://dx.doi.org/10.1152/ajpregu.00735.2009.
13. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002; 3:7; PMID:12098359; http://dx.doi.org/ 10.1186/1471-2172-3-7.
14. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011; 12:1035-44; PMID:22012443; http://dx.doi.org/10.1038/ni.2109.
15. Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev 2008; 22:1747-52; PMID:18593877; http://dx.doi.org/10.1101/gad.465908.
16. Escoll P, del Fresno C, García L, Vallés G, Lendínez MJ, Arnalich F, et al. Rapid upregulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003; 311:465-72; PMID:14592437; http://dx.doi.org/10.1016/j.bbrc.2003.10.019.
17. Piao W, Song C, Chen H, Diaz MA, Wahl LM, Fitzgerald KA, et al. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFNbeta-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009; 86:863-75; PMID:19656901; http://dx.doi.org/10.1189/jlb.0309189.
18. Von Knethen AA, Brune B. Delayed activation of PPARgamma by LPS and IFNgamma attenuates the oxidative burst in macrophages. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2001; 15:535-44.
19. Standiford TJ, Kuick R, Bhan U, Chen J, Newstead M, Keshamouni VG. TGFβ-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene 2011; 30:2475-84; PMID:21278795; http://dx.doi.org/10.1038/onc.2010.619.
20. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011; 186:7243-54; PMID:21576504; http://dx.doi.org/10.4049/jimmunol.1001952.
21. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11:936-44; PMID:20729857; http://dx.doi.org/10.1038/ni.1920.
22. Whitmore MM, Iparraguirre A, Kubelka L, Weninger W, Hai T, Williams BR. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 2007; 179:3622-30; PMID:17785797.
23. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011; 470:279-83; PMID:21160473; http://dx.doi.org/10.1038/nature09692.
24. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008; 132:311-22; PMID:18243105; http://dx.doi.org/10.1016/j.cell. 2007.12.014.
25. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010; 32:317-28; PMID:20206554; http://dx.doi.org/10.1016/j.immuni.2010.02.008.
26. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010; 38:576-89; PMID:20513432; http://dx.doi.org/10.1016/j.molcel.2010.05.004.
27. Arranz A, Androulidaki A, Zacharioudaki V, Martinez C, Margioris AN, Gomariz RP, et al. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol Immunol 2008; 45:2970-80; PMID:18336909; http://dx.doi.org/10.1016/j.molimm.2008.01.023.
28. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009; 31:220-31; PMID:19699171; http://dx.doi.org/10.1016/j.immuni.2009.06.024.
29. Lee YG, Lee J, Byeon SE, Yoo DS, Kim MH, Lee SY, et al. Functional role of Akt in macrophage-mediated innate immunity. Front Biosci 2011; 16:517-30; PMID:21196185; http://dx.doi.org/10.2741/3702.
30. van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, et al. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol 2001; 166:582-7; PMID:11123340.
31. Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 2009; 15:369-79; PMID:19665431; http://dx.doi.org/10.1016/j.molmed.2009.06.005.
32. Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, et al. The kinase p38alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol 2008; 9:1019-27; PMID:18677317; http://dx.doi.org/10.1038/ni.1640.
33. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008; 214:161-78; PMID:18161744; http://dx.doi.org/10.1002/path.2284.
34. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220:35-46; PMID:17979838; http://dx.doi.org/10.1111/j.1600-065X.2007.00574.x.
35. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61:1-9; PMID:15644117; http://dx.doi.org/10.1111/j.0300-9475.2005.01534.x.
36. Fukata M, Vamadevan AS, Abreu MT. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009; 21:242-53; PMID:19748439; http://dx.doi.org/10.1016/j.smim.2009.06.005.
37. Li L, Chen SF, Liu Y. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med 2009; 2:48-67; PMID:19436832.
38. Wang X, Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal 2007; 19:1372-82; PMID:17512700; http://dx.doi.org/ 10.1016/j.cellsig.2007.03.013.
39. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, et al. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J 2007; 26:1245-56; PMID:17304211; http://dx.doi.org/10.1038/sj.emboj.7601587.
40. Ruiz-Bonilla V, Perdiguero E, Gresh L, Serrano AL, Zamora M, Sousa-Victor P, et al. Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases. Cell Cycle 2008; 7:2208-14; PMID:18641461; http://dx.doi.org/10.4161/cc.7.14.6273.
41. Efimova T. p38delta mitogen-activated protein kinase regulates skin homeostasis and tumorigenesis. Cell Cycle 2010; 9:498-505; PMID:20090411; http://dx.doi.org/10.4161/cc.9.3.10541.
42. Risco A, Cuenda A. New Insights into the p38gamma and p38delta MAPK Pathways. Journal of signal transduction 2012; 2012:520289.
43. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429:403-17; PMID:20626350; http://dx.doi.org/10.1042/BJ20100323.
44. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol 2001; 21:8213-24; PMID:11689710; http://dx.doi.org/10.1128/MCB.21.23.8213-24.2001.
45. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, et al. Dynamic regulation of pro- and antiinflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 2006; 103:2274-9; PMID:16461893; http://dx.doi.org/10.1073/pnas.0510965103.
46. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 2006; 203:15-20; PMID:16380512; http://dx.doi.org/10.1084/jem.20051753.
47. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006; 4:61-73; PMID:16814733; http://dx.doi.org/10.1016/j.cmet.2006.05.010.
48. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006; 203:131-40; PMID:16380513; http://dx.doi.org/10.1084/jem. 20051794.
49. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204:1057-69; PMID:17485518; http://dx.doi.org/10.1084/jem.20070075.
50. Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V, Jardí M, Caelles C, Serrano AL, et al. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J Cell Biol 2011; 195:307-22; PMID:21987635; http://dx.doi.org/10.1083/jcb.201104053.
51. Bennett AM, Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997; 278:1288-91; PMID:9360925; http://dx.doi.org/10.1126/science.278.5341.1288.
52. Shi H, Boadu E, Mercan F, Le AM, Flach RJ, Zhang L, et al. MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2010; 24:2985-97.
53. Roth RJ, Le AM, Zhang L, Kahn M, Samuel VT, Shulman GI, et al. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice. J Clin Invest 2009; 119:3817-29; PMID:19920356; http://dx.doi.org/10.1172/JCI39054.
54. Serrano AL, Baeza-Raja B, Perdiguero E, Jardí M, Muñoz-Cánoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008; 7:33-44; PMID:18177723; http://dx.doi.org/10.1016/j.cmet.2007.11.011.
55. Guha M, Mackman N. The phosphatidylinositol- 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002; 277:32124-32; PMID:12052830; http://dx.doi.org/10.1074/jbc.M203298200.
56. Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R, Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide- induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol 2008; 180:4218-26; PMID:18322234.
57. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647-58; PMID:17681183; http://dx.doi.org/10.1053/j.gastro.2007.05.022.
58. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR- 181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493-506; PMID:20797623; http://dx.doi.org/10.1016/j.molcel.2010.07.023.
59. Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NFkappaB signaling. J Mol Cell Biol 2011; 3:159-66; PMID:21502305; http://dx.doi.org/10. 1093/jmcb/mjr007.
60. Kim C, Wilcox-Adelman S, Sano Y, Tang WJ, Collier RJ, Park JM. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci USA 2008; 105:6150-5; PMID:18427110; http://dx.doi.org/10.1073/pnas.0800105105.
61. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 2008; 9:1028-36; PMID:18690222; http://dx.doi.org/10. 1038/ni.1644.
62. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, et al. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci USA 2009; 106:17475-80; PMID:19805133; http://dx.doi.org/10.1073/pnas.0908641106.
63. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009; 18:482-96; PMID:18996917; http://dx.doi.org/10.1093/hmg/ddn376.
64. Hsieh CC, Kuro-o M, Rosenblatt KP, Brobey R, Papaconstantinou J. The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY) 2010; 2:597-611; PMID:20844314.
65. Vrailas-Mortimer A, del Rivero T, Mukherjee S, Nag S, Gaitanidis A, Kadas D, et al. A muscle-specific p38 MAPK/Mef2/MnSOD pathway regulates stress, motor function and life span in Drosophila. Dev Cell 2011; 21:783-95; PMID:22014527; http://dx.doi.org/10.1016/j.devcel.2011.09.002.